Literature DB >> 19022627

Medical comorbidity in patients with schizophrenia and alcohol dependence.

Steven L Batki1, Zsuzsa S Meszaros, Katherine Strutynski, Jacqueline A Dimmock, Luba Leontieva, Robert Ploutz-Snyder, Kelly Canfield, Rebecca A Drayer.   

Abstract

BACKGROUND: Schizophrenia and alcohol dependence are major risk factors for a variety of medical problems, yet there has been little research on the medical status of patients in whom both conditions coexist.
METHODS: We assessed the prevalence and severity of medical illness in 80 patients with schizophrenia or schizoaffective disorder and comorbid alcohol use disorders who entered a controlled trial of monitored naltrexone treatment, and analyzed the relationship between medical illness burden and demographic variables, alcohol and other substance use, and psychosis. Participants underwent physical examination, laboratory tests, medical record review and standardized assessments of medical illness burden, alcohol and other substance use, and psychosis. Nested block multiple regression analyses were used to assess the contribution to illness burden made by demographic variables, alcohol and substance use, and psychosis severity.
RESULTS: 83% of participants had at least one chronic medical illness, hypertension being the most common (43%). Medical comorbidity in this cohort was more severe than for schizophrenia patients in the CATIE trial (Chwastiak, L., Rosenheck, R., McEvoy, J.P., Keefe, R.S., Swartz, M.S., Lieberman, J.A., 2006. Interrelationships of Psychiatric Symptom Severity, Medical Comorbidity, and Functioning in Schizophrenia. Psychiatr. Serv., 57(8), 1102-1109.); the prevalence of hypertension, chronic obstructive pulmonary disease, and coronary artery disease, was more than twice greater. Medical illness burden correlated with alcohol use severity, but appeared to be independent of other substance use or psychosis severity.
CONCLUSIONS: Patients with co-occurring alcohol use disorder may have significantly more medical illness burden than patients with schizophrenia or schizoaffective disorder alone. Interventions to reduce alcohol use may be necessary to lessen medical morbidity.

Entities:  

Mesh:

Year:  2008        PMID: 19022627      PMCID: PMC2649875          DOI: 10.1016/j.schres.2008.10.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study.

Authors:  R G McCreadie
Journal:  Br J Psychiatry       Date:  2003-12       Impact factor: 9.319

2.  Medical morbidity, mental illness, and substance use disorders.

Authors:  Barbara Dickey; Sharon-Lise T Normand; Roger D Weiss; Robert E Drake; Hocine Azeni
Journal:  Psychiatr Serv       Date:  2002-07       Impact factor: 3.084

3.  Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia.

Authors:  Lydia A Chwastiak; Robert A Rosenheck; Joseph P McEvoy; Richard S Keefe; Marvin S Swartz; Jeffrey A Lieberman
Journal:  Psychiatr Serv       Date:  2006-08       Impact factor: 3.084

Review 4.  Medical illness in patients with schizophrenia.

Authors:  L S Goldman
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

5.  Mortality in male alcoholics after ten to fourteen years.

Authors:  B I Liskow; B J Powell; E C Penick; E J Nickel; D Wallace; J F Landon; J Campbell; P J Cantrell
Journal:  J Stud Alcohol       Date:  2000-11

6.  Comorbid schizophrenia and substance abuse.

Authors:  Alan I Green; E Sherwood Brown
Journal:  J Clin Psychiatry       Date:  2006-09       Impact factor: 4.384

7.  Medical assessment in drug addicts: reliability and validity of the Cumulative Illness Rating Scale (Substance Abuse version).

Authors:  Claudio Castillo; Antoni Bulbena; Enric Serras; Marta Torrens; José Luís López-Colomés; María-Alba Martínez; Barbara Politinska
Journal:  Eur Addict Res       Date:  2004       Impact factor: 3.015

8.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

9.  Burden of medical illness in drug- and alcohol-dependent persons without primary care.

Authors:  Israel De Alba; Jeffrey H Samet; Richard Saitz
Journal:  Am J Addict       Date:  2004 Jan-Feb

10.  Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services.

Authors:  Joseph Sokal; Erick Messias; Faith B Dickerson; Julie Kreyenbuhl; Clayton H Brown; Richard W Goldberg; Lisa B Dixon
Journal:  J Nerv Ment Dis       Date:  2004-06       Impact factor: 2.254

View more
  16 in total

1.  Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.

Authors:  Zsuzsa Szombathyne Meszaros; Jacqueline A Dimmock; Robert J Ploutz-Snyder; Ynesse Abdul-Malak; Luba Leontieva; Kelly Canfield; Steven L Batki
Journal:  Am J Addict       Date:  2011-07-18

Review 2.  Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review.

Authors:  Martyna Sawicka; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2017-05-24

3.  Chronic illness histories of adults entering treatment for co-occurring substance abuse and other mental health disorders.

Authors:  Nicholas J Chesher; Chad A Bousman; Maiken Gale; Sonya B Norman; Elizabeth W Twamley; Robert K Heaton; Ian P Everall; Patricia A Judd
Journal:  Am J Addict       Date:  2011-12-15

4.  Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness.

Authors:  Stanley N Caroff; Shirley H Leong; Daisy Ng-Mak; E Cabrina Campbell; Rosalind M Berkowitz; Krithika Rajagopalan; Chien-Chia Chuang; Antony Loebel
Journal:  Community Ment Health J       Date:  2017-12-28

5.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

6.  Accuracy of self-reported medical problems in patients with alcohol dependence and co-occurring schizophrenia or schizoaffective disorder.

Authors:  Zsuzsa Szombathyne Meszaros; Jacqueline A Dimmock; Robert Ploutz-Snyder; Sumerendra Vir Singh Chauhan; Ynesse Abdul-Malak; Frank A Middleton; Steven L Batki
Journal:  Schizophr Res       Date:  2011-08-17       Impact factor: 4.939

7.  Non-psychiatric hospitalization length-of-stay for patients with psychotic disorders: A mixed methods study.

Authors:  Guy M Weissinger; J Margo Brooks Carthon; Bridgette M Brawner
Journal:  Gen Hosp Psychiatry       Date:  2020-07-31       Impact factor: 3.238

8.  Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders.

Authors:  Katherine E Watkins; Susan M Paddock; Teresa J Hudson; Songthip Ounpraseuth; Amy M Schrader; Kimberly A Hepner; Greer Sullivan
Journal:  J Subst Abuse Treat       Date:  2016-06-07

9.  Suicidal behavior and alcohol abuse.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Giovanni Dominici; Stefano Ferracuti; Giorgio D Kotzalidis; Giulia Serra; Paolo Girardi; Luigi Janiri; Roberto Tatarelli; Leo Sher; David Lester
Journal:  Int J Environ Res Public Health       Date:  2010-03-29       Impact factor: 3.390

Review 10.  Dissecting Molecular Genetic Mechanisms of 1q21.1 CNV in Neuropsychiatric Disorders.

Authors:  Joy Yoon; Yingwei Mao
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.